1-7 of 7
Authors: Patricia J. Zettler
Journal Article
Mifepristone, preemption, and public health federalism
Journal of Law and the Biosciences, Volume 9, Issue 2, July-December 2022, lsac037, https://doi.org/10.1093/jlb/lsac037
Published: 21 December 2022
Journal Article
The promise of direct-to-consumer COVID-19 testing: ethical and regulatory issues
Journal of Law and the Biosciences, Volume 7, Issue 1, January-June 2020, lsaa069, https://doi.org/10.1093/jlb/lsaa069
Published: 23 September 2020
Journal Article
Regulatory flexibility for COVID-19 research
Journal of Law and the Biosciences, Volume 7, Issue 1, January-June 2020, lsaa057, https://doi.org/10.1093/jlb/lsaa057
Published: 07 July 2020
Journal Article
The stem cell market and policy options: a call for clarity
Journal of Law and the Biosciences, Volume 5, Issue 3, December 2018, Pages 743–758, https://doi.org/10.1093/jlb/lsy025
Published: 20 November 2018
Journal Article
Is it ‘gene therapy’?
Journal of Law and the Biosciences, Volume 5, Issue 3, December 2018, Pages 786–793, https://doi.org/10.1093/jlb/lsy020
Published: 18 September 2018
Journal Article
What lies ahead for FDA regulation of tDCS products?
Journal of Law and the Biosciences, Volume 3, Issue 2, August 2016, Pages 318–323, https://doi.org/10.1093/jlb/lsw024
Published: 12 July 2016
Journal Article
Regulating drug promotion to promote the public health: a response to Bennett et al.
Journal of Law and the Biosciences, Volume 2, Issue 3, November 2015, Pages 712–716, https://doi.org/10.1093/jlb/lsv050
Published: 05 November 2015
